Clinical Trial Results:
A Randomised, double blind, Placebo controlled, double dummy, parallel group, multicentre, dose ranging study in subjects with T2DM to evaluate the efficacy, safety, and tolerability of orally administered SGLT2 inhibitor JNJ-28431754 with Sitagliptin as a reference arm
Summary
|
|
EudraCT number |
2007-006693-28 |
Trial protocol |
GB CZ BG |
Global completion date |
28 Jan 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Jun 2016
|
First version publication date |
10 Jun 2016
|
Other versions |
|
Summary report(s) |
28431754DIA2001_(2007-006693-28)_(Canagliflozin) Ct.Gov Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.